Table 1 Patient demographics and disease characteristics at baseline
Parameter | Value (N = 50) |
|---|---|
Mean age (range), years | 69.3 (44–91) |
Men,% | 58 |
Race/ethnicity,% | |
White | 86.0 |
Black/African American | 8.0 |
Asian | 2.0 |
Pacific Islander | 2.0 |
Other | 2.0 |
Mean body mass index (SD), kg/m2 | 25.0 (4.37) |
Myelofibrosis subtype,% | |
PMF | 62.0 |
PPV-MF | 30.0 |
PET-MF | 8.0 |
DIPSS risk category,% | |
High | 20.0 |
Intermediate-2 | 62.0 |
Intermediate-1 | 18.0 |
ECOG status,% | |
0 | 12.0 |
1 | 74.0 |
2 | 12.0 |
Missing | 2.0 |
History of transfusion in 12 weeks before baseline,% | 40.0 |
Previous HU use,% | 44.0 |
Mean platelet count (SD), × 109/L | 72.1 (21.9) |
Mean hemoglobin (SD), g/L | 97.3 (15.7) |
Mean WBC (SD), × 109/L | 19.6 (20.2) |
Mean TSS (SD) | 19.4 (11.8) |
Mean spleen length (SD), cm | 13.4 (7.2) |
Mean spleen volume (SD), cm3 | 2387.3 (1527.3) |